Protease resistance of food proteins: a mixed picture for predicting allergenicity but a useful tool for assessing exposure
Clinical and Translational Allergyvolume 8, Article number: 30 (2018)
Susceptibility to pepsin digestion of candidate transgene products is regarded an important parameter in the weight-of-evidence approach for allergenicity risk assessment of genetically modified crops. It has been argued that protocols used for this assessment should better reflect physiological conditions encountered in representative food consumption scenarios.
To evaluate whether inclusion of more physiological conditions, such as sub-optimal and lower pepsin concentrations, in combination with pancreatin digestion, improved the performance of digestibility protocols used in characterization of protein stability.
Four pairs of established allergens and their related non/weakly-allergenic counterparts (seed albumins, muscle tropomyosins, plant lipid transfer proteins [LTP] and collagens) plus fish parvalbumin, were subjected to nine combinations of pH (1.2–2.5–4.0) and pepsin-to-protein ratio (PPR: 10–1–0.1 U/µg) for pepsin digestion, followed by pancreatin digestion in the presence of bile salts. Digestion was monitored by SDS-PAGE in conjunction with Coomassie staining and immunoblotting using rabbit antisera and human IgE.
At pH 4.0 and at PPR 0.1 most proteins, both allergen and non-allergen, were highly resistant to pepsin. Under conditions known to favor pepsin proteolysis, the established major allergens Ara h 2, Pru p 3 and Pen a 1 were highly resistant to proteolysis, while the allergen Cyp c 1 was not. However, this resistance to pepsin digestion only made Ara h 2 and to a lesser extent Pen a 1 and Pru p 3 stand out compared to their non-allergenic counterparts. Largely irrespective of preceding pepsin digestion conditions, pancreatin digestion was very effective for all tested proteins, allergens and non-allergens, except for Cyp c 1 and bovine collagen.
Sub-optimal pH, low pepsin-to protein ratio, and sequential pepsin and pancreatin digestion protocols do not improve the predictive value in distinguish allergens from non-allergens. Digestion conditions facilitating such distinction differ per protein pair.
Allergenicity assessment is an important element of the overall risk assessment for genetically modified (GM) foods [1,2,3,4]. There is no single parameter that can predict whether a transgenic protein is going to behave as an allergen. When developing new GM traits, developers avoid the introduction of established allergens, and in the extension of that, also of molecules that may turn out to be cross-reactive with established allergens. Sequence databases such as AllergenOnline  or the COMPARE database  maintain a comprehensive list of molecules (and their primary sequences) that are reported to be allergens, based on proven IgE binding . Sequence comparison of a candidate transgenic protein with sequences in an allergen database is an important step in the weight-of-evidence approach for allergenicity risk assessment [1,2,3,4, 8]. Another element to take into consideration in allergenicity risk assessment of a transgenic protein is its resistance to digestion by proteolytic enzymes from the gastro-intestinal (GI) tract [9,10,11,12,13,14,15]. The idea behind resistance to digestion as one of determinants of potential allergenicity is quite intuitive, since for readily digested proteins only small amount of the ingested protein molecule would reach the gut immune system in a sufficiently intact state and stimulate it to produce IgE antibodies or to trigger effector cells to induce allergic symptoms beyond the oral/esophageal tract. In this context, it is however important to realize that sensitization to food allergens may also occur via different routes than the gut such as the skin or the respiratory tract [16, 17], where resistance to pepsin or pancreatin is of no relevance. Moreover, if a rather labile protein is present at high concentrations, sufficient protein may survive proteolysis to cause systemic allergic symptoms. Thus, resistance to digestion is a parameter to consider in a weight-of-evidence approach to assess potential allergenicity risks.
The first report to systematically evaluate the utility of pepsin resistance testing as a parameter to help discriminate allergens from non-allergens was by Astwood et al. . They evaluated 16 allergens and 9 non-allergens of plant origin using a protocol for pepsin digestion at pH 1.2 and a high pepsin-to-protein ratio (w/w: 19-fold). Unfortunately, this work did not clearly describe how many units of pepsin per weight of test protein this equates to. The conclusion from this study was that resistance to pepsin digestion clearly separates allergens from non-allergens. Several other reports followed up on those observations with conflicting results, demonstrating that not all food allergens are resistant to pepsin and not all non-allergens susceptible . In part this is explained by the fact that the protocols used in these studies were not comparable, with different pH ranges (mainly ranging from 1.0 to 2.5, and only in a few cases pH 3.0 or 4.0), different pepsin to protein ratios (differing up to 4 orders of magnitude), and different incubation times. A number of studies also included pancreatin digestion in their assessment of a more limited number of molecules . This brief review of conducted tests indicates that protocols differed significantly resulting in allergens being both resistant or susceptible proteins.
Apart from the fact that the lack of protocol standardization has made it difficult to reliably evaluate the discriminatory potential of resistance to pepsin digestion for allergenicity risk assessment, many of the studies have used conditions that have been criticized as not being representative of physiological conditions, i.e. too high pepsin-to-protein ratios, bias by optimal pH for pepsinolysis (around pH 2) while real life gastric pH values are often much higher (e.g. at young age or under influence of proton-pump inhibitors), not including pancreatin digestion, and not taking co-factors such as surfactants and food matrices into account .
To accommodate some of these criticisms, the objective of the present study was to compare resistance to GI digestion using a total of nine combinations of assay conditions of three different pHs during pepsin digestion (1.2, 2.5 and 4.0) and three pepsin-to-protein ratios (10, 1 and 0.1 U/µg), followed by pancreatin digestion with pancreatin in the presence of bile salts. Five established ‘complete allergens’ (shrimp tropomyosin [Pen a 1], peach lipid transfer protein [Pru p 3], peanut 2S albumin [Ara h 2], fish collagen and carp parvalbumin [Cyp c 1] and four of their respective functional non/low allergenic homologues (porcine tropomyosin, strawberry lipid transfer protein [Fra a 3], pea PA2 albumin and bovine collagen) were subjected to the nine digestion conditions and analyzed, using SDS-PAGE and Western blotting to evaluate stability, at 7 time-points. The overall aim was to accommodate some of the conditional variables that may constitute a more physiologically relevant platform for determining pepsin enzyme resistance.
Materials and methods
For detection of test proteins on immunoblot, rabbit polyclonal antisera instead of monoclonal antisera were used to increase the chance of recognition of peptides appearing during digestion. Five rabbit antibody reagents were commercially available: anti-porcine tropomyosin (Thermo Scientific, Waltham, MA, USA), anti-shrimp tropomyosin (Indoor Biotechnologies, Cardiff, UK), anti-fish collagen (Acris, San Diego, CA, USA), anti-bovine collagen (Biologo, Kronshagen, Germany), and anti-Ara h 2 (Indoor Biotechnologies, Cardiff, UK). Anti-pea albumin was custom produced with the same green pea albumin purified for this study (Charles River, Romans, France). Antiserum used for the detection of both peach and strawberry LTP was raised by immunization with recombinant apple LTP, resulting in broadly cross-reactive antibodies against plant LTPs, as described previously . Rabbit antiserum against carp parvalbumin was raised by immunization with recombinant Cyp c 1 as described previously .
For IgE immunoblotting, serum samples with established IgE reactivity to Pru p 3/Fra a 3, Ara h 2, Pen a 1 and Cyp c 1, respectively, from an in-house reference serum bank were used. For both collagens, serum samples with IgE reactivity were not available. A panel of serum samples (n = 12) from green pea sensitized subjects was screened for IgE reactivity against pea PA2 albumin, but none of the samples recognized the protein.
Five out of nine purified proteins were purchased commercially: pig tropomyosin (Sigma, St. Louis, MO, USA), bovine collagen type 1 (ThermoFisher Scientific, Rockford, IL, USA), fish collagen type 1 (Eonova-coll, Debrecen, Hungary), shrimp tropomyosin and peanut Ara h 2 (Indoor Biotechnologies). Pea PA2 albumin was purified from dried green peas as described by Vioque et al. . Carp parvalbumin was purified from fresh carp muscle as described by Kuehn et al. . Both strawberry and peach LTP were expressed in Escherichia coli Rosetta-gami 2 (DE3) pLysS strain as described previously [18, 22]. In short, bacteria were grown at 37 °C, 200 rpm until the OD600 reached 0.6. Expression of LTP was induced by adding 1 mM IPTG, followed by 5 h of culturing at 30 °C. Subsequently cells were lysed by addition of lysozyme and then sonicated; following centrifugation, the supernatant was used for purification of both recombinant LTPs. Purification was based on ion exchange chromatography (IEC) using an ÄKTA ™ Purifier 10 system (GE Healthcare, Hoevelaken, NL): first a separation on an SP Sepharose FF column (cation exchanger), then a desalting step on a HiPrep 26/10 desalting column, followed by a second separation on a MonoQ 5/50 GL column (anion exchanger). For Fra a 3, separation on an extra MonoS column (cation exchanger) was added as a last IEC step. The final purified preparations were concentrated by ultrafiltration over a 3 kDa (YM-3) cut-off filter (Amicon, Darmstadt, Germany).
All purified proteins (see Table 1) were aliquoted in 400 µl portions and stored at − 20 °C until further use, at a protein concentration of 1 mg/ml (water), except the collagens that were stored at 2 mg/ml. Percent identity of pairs of proteins were determined using Clustal W.
Combined pepsin and pancreatin digestion protocol
For pepsin digestion, three concentrations of pepsin 10, 1, and 0.1 U/µg test protein were made in solutions of 0.2% NaCl that were adjusted to either pH 1.2, 2.5, or 4.0, resulting in a total of 9 assay conditions. The pepsin stock solution (Sigma) had a specific activity of 3850 U/mg as provided by the manufacturer. For both collagens the pepsin concentrations were doubled to have the same pepsin-to-protein ratios. For each protein, a total of nine different simulated gastric fluids (SGF) were used. SGF without test protein (1710 µl) was pre-incubated in a water bath for 5 min at 37 °C, after which 90 µl of aliquoted test protein was added. For each time point a separate tube was used for digestion: t = 0 (sample G0), t = 5 min (G5), t = 10 min (G10) and t = 60 min (G60). At these time points, pH was adjusted to pH 7.5 using 1 M NaOH, to inactivate the pepsin. For the G0 sample, inactivation was done before addition of the test protein. Before adding pancreatin for the pancreatin digestion phase, bile salt solution in 50 mM KH2PO4/K2HPO4 was added resulting in a final concentration of 3.2 mM KH2PO4/K2HPO4 and 4 mM of both sodiumtaurocholate and sodiumglycodeoxycholate (both from Sigma).
Each of the remaining pepsin digestion samples (with inactivated pepsin and bile salts) then served as starting point for the pancreatin digestion. First, a 100 µl sample was drawn from the four tubes representing the different time points of the pepsin phase, and to this sample inactivated (10 min at 90 °C) pancreatin (Sigma) was added (6.5 µl of 1% w/v in 50 mM KH2PO4/K2HPO4 at pH7.5), giving the 4 different t = 0 samples for pancreatin digestion after pepsin digestion: G0D0, G5D0, G10D0 and G60D0. To the remaining samples 115 µl of the same, but active pancreatin solution was added. Pancreatin digestion was monitored at two time-points, i.e. 10 and 60 min. At both time points, 100 µl samples were drawn that were immediately inactivated by adding a mix of NuPAGE sample buffer and NuPAGE reducing agent (see below). This resulted in the following samples: G0D10 and G0D60, G5D10 and G5D60, G10D10 and G10D60, and G60D10 and G60D60. An overview of the sampling scheme is presented in Fig. 1.
For SDS-PAGE and Western blotting 100 µl samples were drawn, which were mixed with NuPAGE LDS sample buffer and NuPAGE reducing (Invitrogen, Carlsbad, CA, USA) in a ratio (v/v/v) of 13:5:2. All samples for SDS-PAGE and Western blotting analyses were heated for 10 min at 70 °C and then stored at − 20 °C until use.
SDS-PAGE and Western blotting
Proteins (18 μl sample per lane) were separated by SDS-PAGE (NuPAGE® 4–12% Bis-Tris gel; NuPAGE® 3–8% for the collagens; Invitrogen) and Western blotting was performed by transferring the proteins semi-dry to nitrocellulose on a Novablot electrophoretic transfer apparatus, according to the protocol of the manufacturer (Invitrogen). After blocking with PBS/5% skim milk powder/0.1% Tween-20 for a minimum of 10 min, the blots were incubated overnight with appropriate dilutions of polyclonal rabbit antisera in 12.5 ml of PBS/0.1% Tween-20/0.5% skim milk powder. After washing 5 times (PBS/0.1% Tween-20), blots were incubated (4 h) with IRDye800CW-labeled goat anti-rabbit IgG (Licor Biotechnology, NE, USA) and subsequently washed as before. The IRDye800-labeled proteins were detected by infrared scanning using Odyssey V3.0 scanning software (Westburg, Leusden, The Netherlands).
Lipid transfer proteins
Lipid transfer proteins (LTP) from peach and strawberry were obtained as purified recombinant proteins, Pru p 3 and Fra a 3, respectively, with the former being an established major allergen and the latter a weak allergen [22, 23]. Overall, both LTPs were equally resistant to pepsin digestion at all nine combinations of pH and pepsin-to-protein ratios (PPRs) when judged by SDS-PAGE in conjunction with Coomassie staining (Fig. 2A). However, at time points 10 and 60 min (pH 1.2 and 2.5) rabbit IgG antibody staining showed a decrease in detection for both peach and strawberry LTP, again at all nine pHs and PPRs. This loss of antibody binding appeared to be greater for Fra a 3 (shown for pH1.2 with PPR 10 and 0.1 in Fig. 2A), although it cannot be fully excluded that this is (in part) explained by lower sensitivity of the rabbit antiserum for Fra a 3 compared to Pru p 3.
Exposure to pepsin for 5 min at pH 1.2 irrespective of the PPR made Fra a 3 highly susceptible to subsequent pancreatin digestion, as judged by both SDS-PAGE and immunoblotting. Although some digestion of Pru p 3 by pancreatin also occurred, this was only observed following exposure to the highest pepsin concentration (Fig. 2B). Both LTPs were completely digested by pancreatin after 10 min, following pepsin digestion at pH 2.5 and at pH 4.0, with any PPR. This was even true for the associated negative control samples for pepsin digestion (G0D0) that were neutralized (pH 7.5) prior to addition of LTP, i.e. they had not been exposed to acidic pH conditions at all. At the first time point of pancreatin digestion (G0D10), both Fra a 3 and Pru p 3 in these negative control samples were undetectable on SDS-PAGE and by immunoblotting (shown for PPR 10 in Fig. 2B).
Some digesta were also used for IgE immunoblotting (Fig. 2C). The complete disappearance of antibody binding to Fra a 3 after 10 min exposure to pepsin (PPR 10) was not observed using IgE. On the other hand, the higher susceptibility of Fra a 3 to subsequent pancreatin digestion was confirmed using IgE antibodies.
Purified natural peanut 2S albumin Ara h 2, an established allergen, and green pea PA2 albumin (PA2), a weak/non-allergen are both abundant seed storage proteins, but have no significant sequence homology (5%). At pH 1.2 with PPR 10 and 1, PA2 was not detected after 5 min of pepsin digestion, both on SDS-PAGE and immunoblot (shown for PPR 1 in Fig. 3A). At PPR 0.1 truncated bands of PA2 remained detectable up to 1 h of pepsin digestion (Additional file 1: Fig. E1a). Ara h 2 was highly resistant to pepsin digestion at pH 1.2, with the higher band of the Ara h 2 doublet staying visible up to 1 h, even with the highest dose of pepsin (Additional file 1: Fig. E1b). At PPR1, the Ara h 2 doublet remained intact (Fig. 3A). Ara h 2 appeared slightly more susceptible to pepsinolysis at pH 2.5 than at pH 1.2 (Additional file 1: Fig. E1c). In contrast, pea albumin was clearly more resistant at pH 2.5 than at pH 1.2 with the PPRs 10 and 1 (shown for PPR 1 in Additional file 1: Fig. E1d). At pH 4.0, for both albumins no significant digestion was observed (Fig. 3A).
Pepsin digestion of Ara h 2 at pH 2.5 and pH 4.0 made it highly susceptible to pancreatin digestion. At all three PPRs the protein doublet had completely disappeared at 10 min in both SDS-PAGE and immunoblotting (shown for pH 4.0/PPR 1 in Fig. 3B). Pepsin digestion at pH 1.2 (but also in the negative control samples that had not been exposed to acidic pH) followed by pancreatin digestion resulted in an unexpected observation: after 10 min in pancreatin, the Ara h 2 doublet almost disappeared, but at 60 min the bands increased in intensity again. This phenomenon was observed reproducibly independent of the preceding PPR, but was most obvious at PPR 1 (Fig. 3B). Judged by immunoblotting, PA2 was slightly more resistant to pancreatin digestion than Ara h 2 (shown for PPR 1 in Fig. 3B).
IgE immunoblotting confirmed the high resistance of Ara h 2 to pepsin digestion (shown for pH 1.2/PPR 1 in Fig. 3C). Also, for IgE antibodies, pancreatin exposure of Ara h 2 following pepsin digestion at pH 4 resulted in complete disappearance of IgE binding. Finally, the reduction and subsequent increase of antibody binding observed for negative control samples (G0D0) under influence of pancreatin was also observed for IgE antibodies, albeit less convincingly (Fig. 3C).
Shrimp tropomyosin Pen a 1, an established allergen, was truncated by pepsin at pH 1.2 with PPR 10 and PPR 1 at 5 and 10 min, followed by further truncation at 60 min (Fig. 4A). Truncated peptides slightly below the molecular mass of the native protein as well as smaller peptides cleaved off were still detected on immunoblot. At pH 1.2 /PPR 0.1 no cleavage was observed (Additional file 2: Fig. E2a). At pH 2.5, Pen a 1 was much more susceptible to digestion (shown for PPR 10 in Fig. 4A), with truncation observed even at PPR 0.1 (Additional file 2: Fig. E2b). At pH 4.0, with all three PPRs, Pen a 1 was resistant to pepsin digestion (shown for PPR 1 in Fig. 4A).
Pig tropomyosin, a weak/non-allergen, was also truncated by pepsin at pH 1.2/PPR 10, and was not detected by antibodies at 10 min into the pepsin digestion (Fig. 4A). At PPR 1, weak recognition of a truncated band remained present up to 60 min (Fig. 4A). At PPR 0.1, some truncation was only observed after 60 min (Additional file 2: Fig. E2c). At pH 2.5, pig tropomyosin was fully digested at PPR 10 (Fig. 4A), progressively truncated at PPR 1 with only very weak residual antibody recognition at 5 min, and almost unaffected at PPR 0.1 with only slight truncation at 60 min (not shown). At pH 4.0 and PPR 10 or PPR 1, the protein was rapidly digested with no antibody recognition (shown for PPR 1 in Fig. 4A). At pH 4.0/PPR 0.1 some minor truncation was observed, but significant antibody binding persisted (not shown).
Pig tropomyosin was fully digested by pancreatin irrespective of the preceding pepsin digestion conditions (not shown). This was also true for pancreatin digestion of shrimp tropomyosin (shown for pH 2.5/PPR 10 and pH 4.0/PPR 1 in Fig. 4B), except when following pepsin digestion at pH 1.2 in combination with the two higher PPRs. Under those conditions, truncation was observed, with recognition of some lower molecular mass bands on immunoblot up to 60 min of pancreatin digestion (Additional file 2: Fig. E2d).
IgE immunoblotting of shrimp tropomyosin pepsin digestion samples gave comparable results as observed with rabbit antisera (Fig. 4C).
Fish collagen, mainly reported as an allergen in Japanese fish allergic patients [24, 25], was effectively digested by pepsin at the highest PPR, independent of pH (shown for pH 2.5 in Fig. 5A). At lower PPRs resistance increased, both on SDS-PAGE and immunoblot (shown for pH2.5/PPR 1 in Fig. 5A). Bovine collagen, rarely reported to be allergenic , was significantly more resistant to pepsin digestion, with no visible digestion at PPR 0.1 (Additional file 3: Fig. E3). Only at pH 1.2 and in particular pH 2.5 some digestion was observed with PPR 10 (Fig. 5A).
Fish collagen was very susceptible to pancreatin digestion, irrespective of the preceding gastric conditions (shown for pH 2.5/PPR0.1 in Fig. 5B). Bovine collagen on the other hand was quite resistant to pancreatin digestion, in particular when preceded by pepsin digestion at pH 2.5-PPR 0.1 (Fig. 5B).
Carp parvalbumin, an established allergen, was very susceptible to pepsin digestion at pH 1.2 and 2.5, with complete disappearance of the native protein band on SDS-PAGE and with complete loss of antibody binding on immunoblot at all three PPRs (shown for pH 2.5 in Fig. 6A). On SDS-PAGE, with the lower PPRs some cleavage peptides were visible at three molecular masses below the native protein, but these were not recognized by antibodies. At pH 4.0 no decrease in band intensity occurred on SDS-PAGE, but that of antibody binding decreased at 10 and 60 min (Fig. 6A). In contrast to the susceptibility to pepsin, carp parvalbumin proved to be highly resistant to pancreatin digestion both on SDS-PAGE and immunoblot with rabbit IgG (shown for pH 2.5 in Fig. 6B) and with human IgE (Fig. 6C). Susceptibility to pepsin digestion of IgE binding to parvalbumin was confirmed (shown for pH1.2 /PPR 0.1 in Fig. 6C).
Stability to digestion is one of the components of the weight-of-evidence approach for allergenicity risk assessment of novel food proteins. The present study investigated whether distinction of food allergens and non/weakly allergenic food proteins can be achieved with currently applied digestion protocols using optimal conditions for pepsinolysis, and whether performance would improve by using less optimal physiologically occurring conditions, and by sequentially extending such protocols with pancreatin digestion. A schematic overview of the outcome of these studies is given in Table 2, essentially showing that there is no single protocol that allows distinction between allergens and non-allergens based on resistance to digestion.
For the pepsin phase under optimal conditions (pH 1.2/2.5–PPR 10/1), a quite mixed picture emerges (Table 2) with two established major allergens, Pru p 3 and Ara h 2, being highly resistant to pepsin digestion (Figs. 2A, 3A). Alternatively, full-length shrimp tropomyosin was quite susceptible to pepsin digestion, but resulting breakdown peptides retained antibody-binding capacity, both rabbit IgG (Fig. 4A) and human IgE (Fig. 4C). The fourth major allergen, fish parvalbumin, was highly susceptible to pepsin digestion (Fig. 6A).
In the current study, optimal (low) pH with saturating pepsin concentrations clearly distinguished allergen from non-allergen in case of Ara h 2 and pea PA2 albumin, and to a lesser extent both LTPs and tropomyosins (Table 2). In fact, for tropomyosins distinction was best made at pH 4.0–PPR 1 (Fig. 4A). For the collagens, the one with most convincing evidence for allergenicity, fish collagen, turned out to be much more susceptible to pepsin than bovine collagen (Fig. 5A). For fish parvalbumin we did not have a comparison to a poorly allergenic homologue, but the well-established strong allergen carp parvalbumin was highly sensitive to pepsin digestion (Fig. 6A, C), i.e. not fitting the hypothesis that major allergens are pepsin resistant.
A very consistent observation was that pepsin digestion at the higher pH of 4.0 is very ineffective, both for the established allergens and their less allergenic counterparts. Exceptions to these observations were pig tropomyosin and fish collagen, showing breakdown and loss of antibody binding at pH 4.0 with PPR 10 and 1. A pepsin-to-protein ratio of 0.1 was ineffective for digestion of all tested proteins. Overall, therefore, pepsin digestion assays conducted at pH 4.0 and PPR 0.1 are, despite in some ways perhaps being more physiological, not of added value to distinguish allergens from non-allergens: Most proteins are poorly processed under these conditions, irrespective of being an allergen or not. On the other hand, this means that at higher pH, such as occurring during the use of proton-pump inhibitors, more intact protein will reach the intestines. This may translate into a higher risk of allergic symptoms, but this will of course also depend on the subsequent behavior during pancreatin digestion.
Pancreatin digestion is currently not routinely combined with pepsin digestion in protocols applied for allergenicity risk assessment. Here we have tested this combination for all nine conditions of pepsin digestion. Carp parvalbumin that only survived pepsin digestion at pH 4.0 was completely resistant to pancreatin digestion, a finding that seems to be in accordance with in vivo studies . Quite surprisingly, the other three established allergens Ara h 2, Pru p 3 and Pen a 1 were highly susceptible to pancreatin after having survived pepsin digestion at pH 2.5 and pH 4.0 in combination with all three PPRs (Table 2). All three allergens were completely digested at the first time-point (10 min) of the pancreatin phase. In terms of using the addition of the pancreatin digestion as a means of distinguishing allergens from their non-allergenic counterparts this did however not really help. Examples of this inconsistency include Fra a 3 and pig tropomyosin which were equally susceptible as their allergenic counterparts, and the expected low allergenic pea albumin appeared slightly more stable than the peanut protein, Ara h 2.
After pre-treatment with pepsin at pH 1.2 variable resistance to pancreatin digestion was observed (Table 2). Pru p 3 showed a moderate decrease only after pre-treatment with the highest pepsin concentration, but was unaffected by pancreatin after PPRs 1 and 0.1. This clearly distinguishes this major allergen from its weakly allergenic homologue Fra a 3 that was fully digested under all conditions. In contrast, shrimp Pen a 1 allergen was clearly digested by pancreatin into a ladder of truncated and lower molecular mass bands that remained reactive on immunoblot, after pepsin pre-treatment with PPRs 10 and 1, but was completely digested after PPR 0.1. Its pig homologue was highly susceptible to pancreatin digestion irrespective of the preceding pepsin digestion conditions, allowing distinction of the allergenic Pen a 1 from its non-allergenic pig homologue. Ara h 2 showed a quite unexpected behavior during pancreatin digestion after pepsin digestion at pH 1.2, independent of the PPR: Both on SDS-PAGE and on immunoblot, the typical Ara h 2 doublet clearly decreased in the presence of pancreatin at 10 min but increased again to an intensity close to that observed at t = 0. We have no explanation for these observations, but one could speculate that processes like transient aggregation and/or reassembly after clipping of the molecule. Pea PA2 albumin overall displayed a higher resistance to pancreatin than Ara h 2 (Table 2). Overall, one may conclude that, in combination with proposed more physiological conditions of pepsin digestion (pH 2.5–4.0), the addition of a pancreatin phase does not improve the power to discriminate allergens from non-allergens. After an exposure to pepsin at pH 2.5 or 4.0, the stability differences between allergens and non-allergens are inconsistent with no added capability to characterize stability of the protein in the presence of either pepsin or pancreatin.
In summary, this study has challenged the paradigm that there is a straightforward relation between resistance to GI pepsin digestion and allergenicity. Of the four established allergens tested, fish parvalbumin was highly susceptible to pepsin but very resistant to pancreatin. For the other three it was essentially the other way around: quite resistant to pepsin but highly susceptible to pancreatin, in particular if preceded by supposedly more physiological conditions for the pepsin phase. Having said that, neither susceptibility to pepsin nor to pancreatin can characterize whether a candidate protein is likely to be an allergenic hazard. In order to support a revision to the existing low pH, high PPR assay format, the observations that emerged with the pairs of protein would have to be much more consistent than data demonstrate herein. A piece of the puzzle still missing is what role the food matrix may play in determining the digestibility of proteins. It is quite plausible that protein in a matrix may be less accessible to proteolytic enzymes and consequently less susceptible to digestion than a purified protein in aqueous solution.
The paradigm of resistance to GI proteolysis being a key, but not fully consistent characteristic of allergens does in fact not survive the scrutiny of the present assessment, i.e. not for predicting whether a protein is likely to be or become an allergen. Having said that, resistance to digestion is relevant for the simple reason that relatively higher resistance (both intactness and time to digestion) to pepsin and/or pancreatin will facilitate a higher quantity of any protein, allergen or non-allergen, delivered to the intestinal immune system and potentially cause systemic allergic reactions in those previously sensitized. In this context, the resistance to digestion is in relation to foods consumed. As such, the current practice to evaluate resistance to pepsin digestion is a relevant consideration in the allergenicity risk assessment of novel proteins that should be taken along, mostly as an exposure assessment in the weight-of-evidence approach . The addition of a sequential pancreatin (duodenal) phase to follow the pepsin digestion phase does not improve the power to discriminate allergens from non-allergens. However, with the susceptibility profile of parvalbumin in mind, it is probably valuable to extend the current practice of pepsin digestion protocols (optimal pH and PPR)  with a stand-alone pancreatin digestion protocol. Together these separate assays provide a platform to measure a protein’s relative intactness and the rate at which pepsin and pancreatin digest a protein. The assays in this regard support an assessment of whether a protein may survive GI digestion in sufficiently high quantity and integrity to induce systemic reactions.
lipid transfer protein
pepsin to protein ratio
sodium dodecyl sulfate polyacrylamide gel electrophoresis
simulated gastric fluid
FAO/WHO. Evaluation of allergenicity of genetically modified foods. Report of a joint FAO/WHO expert consultation on allergenicity of foods derived from biotechnology. Rome: Food and Agriculture Organization of the United Nations; 2001.
Codex Alimentarius Commission. Appendix III, Guideline for the conduct of food safety assessment of foods derived from recombinant-DNA plants and Appendix IV, Annex on the assessment of possible allergenicity. Alinorm 03/34: Joint FAO/WHO Food Standard Programme, Codex Alimentarius Commission, Twenty-Fifth Session, Rome, 30 June–5 July, 2003. Rome, Italy: Codex Alimentarius Commission; 2003. p. 47-60.
Ladics GS, Bannon GA, Silvanovich A, Cressman RF. Comparison of conventional FASTA identity searches with the 80 amino acid sliding window FASTA search for the elucidation of potential identities to known allergens. Mol Nutr Food Res. 2007;51:985–98.
Goodman RE, Vieths S, Sampson HA, Hill D, Ebisawa M, Taylor SL, et al. Allergenicity assessment of genetically modified crops–what makes sense? Nat Biotechnol. 2008;26:73–81.
AllergenOnline Database. 2017.
COMprehensive Protein Allergen REsource (COMPARE) Database. 2017.
Goodman RE, Ebisawa M, Ferreira F, Sampson HA, van Ree R, Vieths S, et al. AllergenOnline: a peer-reviewed, curated allergen database to assess novel food proteins for potential cross-reactivity. Mol Nutr Food Res. 2016;60:1183–98.
Silvanovich A, Bannon G, McClain S. The use of E-scores to determine the quality of protein alignments. Regul Toxicol Pharmacol RTP. 2009;54:S26–31.
Astwood JD, Leach JN, Fuchs RL. Stability of food allergens to digestion in vitro. Nat Biotechnol. 1996;14:1269–73.
Huby RD, Dearman RJ, Kimber I. Why are some proteins allergens? Toxicol Sci Off J Soc Toxicol. 2000;55:235–46.
Fu TJ. Digestion stability as a criterion for protein allergenicity assessment. Ann N Y Acad Sci. 2002;964:99–110.
Fu TJ, Abbott UR, Hatzos C. Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid-a comparative study. J Agric Food Chem. 2002;50:7154–60.
Bannon G, Fu TJ, Kimber I, Hinton DM. Protein digestibility and relevance to allergenicity. Environ Health Perspect. 2003;111:1122–4.
Herman RA, Woolhiser MM, Ladics GS, Korjagin VA, Schafer BW, Storer NP, et al. Stability of a set of allergens and non-allergens in simulated gastric fluid. Int J Food Sci Nutr. 2007;58:125–41.
Bogh KL, Madsen CB. Food allergens: is there a correlation between stability to digestion and allergenicity? Crit Rev Food Sci Nutr. 2016;56:1545–67.
Asero R, Arena A, Cecchi L, Conte ME, Crivellaro M, Emiliani F, et al. Are IgE levels to foods other than rosaceae predictive of allergy in lipid transfer protein-hypersensitive patients? Int Arch Allergy Immunol. 2011;155:149–54.
Brough HA, Liu AH, Sicherer S, Makinson K, Douiri A, Brown SJ, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol. 2015;135:164–70.
Zuidmeer L, van Leeuwen WA, Budde IK, Cornelissen J, Bulder I, Rafalska I, et al. Lipid transfer proteins from fruit: cloning, expression and quantification. Int Arch Allergy Immunol. 2005;137:273–81.
Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, Versteeg SA, Jensen BM, et al. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol. 2015;166:41–51.
Vioque J, Clemente A, Sánchez-Vioque R, Pedroche J, Bautista J, Millán F. Comparative study of chickpea and pea Pa2 albumins. J Agric Food Chem. 1998;46:3609–13.
Kuehn A, Scheuermann T, Hilger C, Hentges F. Important variations in parvalbumin content in common fish species: a factor possibly contributing to variable allergenicity. Int Arch Allergy Immunol. 2010;153:359–66.
Zuidmeer L, Salentijn E, Rivas MF, Mancebo EG, Asero R, Matos CI, et al. The role of profilin and lipid transfer protein in strawberry allergy in the Mediterranean area. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2006;36:666–75.
Fernandez-Rivas M, Gonzalez-Mancebo E, Rodriguez-Perez R, Benito C, Sanchez-Monge R, Salcedo G, et al. Clinically relevant peach allergy is related to peach lipid transfer protein, Pru p 3, in the Spanish population. J Allergy Clin Immunol. 2003;112:789–95.
Sakaguchi M, Toda M, Ebihara T, Irie S, Hori H, Imai A, et al. IgE antibody to fish gelatin (type I collagen) in patients with fish allergy. J Allergy Clin Immunol. 2000;106:579–84.
Kobayashi Y, Akiyama H, Huge J, Kubota H, Chikazawa S, Satoh T, et al. Fish collagen is an important panallergen in the Japanese population. Allergy. 2016;71:720–3.
Sakaguchi MHH, Ebihara T, Irie S, Yanagida M, Inouye S. Reactivity of the immunoglobulin E in bovine gelatin-sensitive children to gelatins from various animals. Immunology. 1999;96:286–90.
Untersmayr E, Vestergaard H, Malling HJ, Jensen LB, Platzer MH, Boltz-Nitulescu G, et al. Incomplete digestion of codfish represents a risk factor for anaphylaxis in patients with allergy. J Allergy Clin Immunol. 2007;119:711–7.
Wang R, Edrington TC, Storrs SB, Crowley KS, Ward JM, Lee TC, et al. Analyzing pepsin degradation assay conditions used for allergenicity assessments to ensure that pepsin susceptible and pepsin resistant dietary proteins are distinguishable. PLoS ONE. 2017;12:e0171926.
Thomas K, Aalbers M, Bannon GA, Bartels M, Dearman RJ, Esdaile DJ, et al. A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins. Regul Toxicol Pharmacol RTP. 2004;39:87–98.
JA: performance of experiments/critically reviewing the manuscript; MT: performance of pilot experiments to establish the experimental protocols; BB: critically reviewing the manuscript; EB: critically reviewing the manuscript; TD: critically reviewing the manuscript; TE: critically reviewing the manuscript; KG: critically reviewing the manuscript/discussing the experimental design; GG: critically reviewing the manuscript; RH: critically reviewing the manuscript/discussing experimental design; AK: critically reviewing the manuscript; GL: critically reviewing the manuscript/discussing experimental design; SM critically reviewing the manuscript/discussing experimental design; LKP critically reviewing the manuscript/discussing experimental design; RR: critically reviewing the manuscript; JBR: critically reviewing the manuscript; HS: critically reviewing the manuscript; DS: mass spectrometry analysis PA2; RW: critically reviewing the manuscript; LPM: critically reviewing the manuscript/discussing experimental design/project management; AC: critically reviewing the manuscript/discussing experimental design; RvR: writing manuscript/coordination of project. All authors read and approved the final manuscript.
We thank Lauren Peel and Brianna Farr at HESI for their support in managing the project.
Muriel Totis, Rakesh Ranjan, Jean-Baptiste Rascle, Hector Serrano, and Annabelle Capt are employees of Bayer CropScience; Brian Barnett was employed by BASF Plant Science; Erin Bell, Thomas Edrington, Kevin Glenn, and Rong Wang are employees of Monsanto Co; Tom Davis and Gregory Ladics are employees of Dupont Pioneer; Rod Herman is an employee of Dow AgrosSciences; Gerson Graser and Scott McClain are employees of Syngenta.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Consent for publication
Ethics approval and consent to participate
This work was supported by the Health and Environmental Sciences Institute (HESI). HESI is a non-profit scientific organization that facilitates public and private partnerships in human and environmental health.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.